Impact of high dose of baricitinib in severe COVID-19 pneumonia: a prospective cohort study in Bangladesh.

BMC Infectious Diseases
Md Jahidul HasanSitesh C Bachar

Abstract

Hyperinflammation in severe COVID-19 infection increases the risk of respiratory failure and one of the cogent reasons of mortality associated with COVID-19. Baricitinib, a janus kinases inhibitor, can potentially suppress inflammatory cascades in severe COVID-19 pneumonia. The objective of this study was to compare the clinical outcomes of high dose of baricitinib with its usual dose in patients with severe COVID-19 pneumonia. This prospective cohort study was conducted on 238 adult patients with severe COVID-19 pneumonia. Eight milligram and 4 mg of baricitinib was given orally to 122 patients in the high dose (HD) group and 116 patients the usual dose (UD) group, respectively daily for 14 days, and clinical outcomes were compared among the groups. Blood oxygen saturation level was stabilized (≥94% on room air) earlier in the HD group compared to the UD group [5 (IQR: 4-5)/8 (IQR: 6-9), P < 0.05]. Patients in the HD group required intensive care unit (ICU) and intubation supports more in the UD group than that in patients of the HD group [17.2%/9%, P < 0.05; 11.2%/4.1%, P > 0.05; N = 116/122, respectively]. The 30-day mortality and 60-day rehospitalization rate were higher in the UD group than the HD group [6%/3.3%, P < 0.01;...Continue Reading

References

Mar 18, 2009·Immunological Reviews·Kamran GhoreschiJohn J O'Shea
Mar 4, 2017·Therapeutic Advances in Musculoskeletal Disease·Bindee KuriyaEd Keystone
Jan 19, 2020·International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases·David S HuiEskild Petersen
Feb 8, 2020·JAMA : the Journal of the American Medical Association·Dawei WangZhiyong Peng
Feb 23, 2020·The Lancet. Respiratory Medicine·Zhe XuFu-Sheng Wang
Feb 29, 2020·The New England Journal of Medicine·Wei-Jie GuanUNKNOWN China Medical Treatment Expert Group for Covid-19
Mar 3, 2020·The Lancet Infectious Diseases·Justin StebbingPeter Richardson
Apr 1, 2020·Global Health Research and Policy·Hengbo ZhuPing Niu
May 8, 2020·Nature Reviews. Immunology·Miriam Merad, Jerome C Martin
May 18, 2020·Internal and Emergency Medicine·Guillaume VoiriotMuriel Fartoukh
May 28, 2020·Cell Biology International·Nazanin Fathi, Nima Rezaei
May 31, 2020·EMBO Molecular Medicine·Justin StebbingUNKNOWN Sacco Baricitinib Study Group
Jun 27, 2020·Journal of Clinical Medicine Research·Subhasish BoseVenu Madhav Konala
Jul 10, 2020·Infection·A CingolaniUNKNOWN for COVID 2 Columbus Working Group
Aug 4, 2020·Euroasian Journal of Hepato-gastroenterology·Muhammad Ar BhuyanSheikh Mf Akbar
Aug 9, 2020·EClinicalMedicine·Yufeng ShangXinghuan Wang
Aug 21, 2020·Journal of General Internal Medicine·Sulaiman S SomaniGirish N Nadkarni
Dec 12, 2020·The New England Journal of Medicine·Andre C KalilUNKNOWN ACTT-2 Study Group Members

❮ Previous
Next ❯

Software Mentioned

Statistical Product and Service Software ( SPSS

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

The Lancet Infectious Diseases
Ennio G FavalliRoberto Caporali
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
Boghuma K TitanjiVincent C Marconi
Journal of Medical Virology
Sergio Lo CaputoTeresa Antonia Santantonio
© 2021 Meta ULC. All rights reserved